Please login to the form below

I have forgotten my password

AZ signs two companion diagnostic deals

Will help identify patients suitable for treatment with lung cancer drugs

Plegridy approval underlines Biogen Idec's dominance in MS

And Tecfidera boosts pharma company’s second quarter financial results

Two blood cancer drugs among CHMP recommendations

Five new drugs, including Janssen’s Imbruvica and Gilead’s Zydelig, backed for use in Europe

Puppet crooner promotes World Hepatitis Day

The World Hepatitis Alliance uses Richard Cheese song to raise awareness

Nexavar fails late-stage breast cancer trial

Bayer’s oncology drug unable to improve progression free survival in new indication

GSK seeks approval for first malaria vaccine

Submits marketing application to European Medicines Agency

FDA approves pain drug that has reduced risk of abuse

Purdue’s Targiniq ER developed to deter snorting and injection

Neupogen will be first biologic on FDA biosimilars pathway

US regulator will review Novartis’ version of Amgen's Neupogen (filgrastim) over the coming months

Turkey aims to become ‘global player’ in biopharma

Government pledges to boost country’s support for medicines access and R&D

Managing pharma's uncertainty

Futures we can’t predict need a strategy we can’t plan

Channel strategy and orphan drugs

A plan for guiding decisions about a product's distribution channel is particularly relevant for orphan drugs, rare diseases or specialty medicines
Navigating the new prescriber network

How to understand critical networks of influence in this multichannel world

More features

FDA approves Gilead drug in three blood cancers

Zydelig recommended for use in chronic lymphocytic leukaemia and two forms of lymphoma
BMJ accuses Boehringer of withholding Pradaxa data

Claims current FDA recommendation for anticoagulant may be flawed
Community pharmacies central to diabetes fight in UK

Risk assessments can help identify people at risk of developing condition
Boehringer goes on PR offensive over Pradaxa report

Takes to social media to defend its position on the anticoagulant ahead of tonight's Channel 4 news report
Merck & Co taps music industry for US HIV campaign

Pharma company to work with music promoter Maria Davis and Positive Women’s Network – USA
Celgene's cancer drug promising in small HIV study

Lymphoma therapy Istodax shows potential in treating the virus
Lilly’s Efient and Sucampo's Amitiza win NICE backing

Blood clot and constipation drugs recommended for NHS use

More news

Latest appointments

Milestone names chief medical officer

Francis Plat bring experience from Merck, Daiichi-Sankyo, Novartis and BMS to the role
Genentech’s Sunil Agarwal joins rare disease firm

He will serve as chief medical officer at Ultragenyx
Philips names head of healthcare for South Asia

Sameer Garde takes role at tech company
Porter Novelli announces new senior health role

New senior VP Amy Nicole Nayar has experience at Pfizer
Neuway appoints Boehringer’s Baiker to board

He has 25 years’ experience at German pharma company

More appointments

Featured jobs

Senior Client Engagement Manager – Health Engagement and Communication...: Excellent salary, pension and company bonus

Senior Account Director/ Account Director, Healthcare Brand Communicat...: Highly Competitive package

Digital Planner – Digital Agency – London: Competitive

Senior Account Manager, Consumer Health/ Digital focus, Excellent pack...: Excellent Package

Account Director/ Senior Account Director, OTC - TV, Digital, PR, Lond...: Highly Competitive package

Associate Director, Client Engagement - Communications - Berkshire: Excellent salary + benefits including pension and company bonus

Business Unit Director, Medical Communications, London, Circa 75K: Circa £80K

Medical Writer/ Consultant, Market Access & HEOR, London, Very com...: Very competitive package

Business Unit Director, Medical Communications, London, Circa £10...: Circa £100-120K

Account Executive: Competitive + excellent benefits
Fleishman-Hillard UK Ltd

Business Development Manager - Healthcare Digital Media: Competitive salary and high commission

Head of Consumer Health - Healthcare PR: Competitive

Head of Client Services, London, Diverse communications agency, circa ...: Circa £80K

Scientific Director, Medical Communications, London, Circa 80K: Circa £80K

Senior Account Executive, Consumer Health/ Medical Communications, Lon...: Highly Competitive package

Group Account Director, Healthcare Advertising, London £80-90K: £80-90K

Medical Writer, Consumer Health/ Medical Communications, London: Highly Competitive package

Account Manager, Consumer Health/ Medical Communications, London: Highly Competitive package

Medical Communications Business Leader, London, £100-120K: £100-120K

Head of Copy, Healthcare Advertising/ Multichannel Agency, SE England,...: Highly Competitive package

Director, Healthcare PR, London, Excellent Package: Excellent Package

Joint Managing Director, Medical Communications, London, £100-120...: £100-120K

Senior Account Manager, Healthcare PR, London, Excellent Package: Excellent Package

Global CEO, Healthcare PR, London or US, Industry leading package: Industry leading package

Subscribe to our email news alerts

PMHub

Add my company

Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

M3 improves personalisation of pharma engagement with doctors: Launches new messaging service on Doctors.net.uk...
Digital Futures 2014 slide deck: Full slides, including survey data, from PMLiVE's digital pharma marketing online event...
The Chinese diabetes challenge: Marketing, communications and commercial relationships in China are full of pitfalls for the unwary, but not without great potential ...